nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy
|
Kinali, Maria |
|
2002 |
12 |
S |
p. S169-S174 6 p. |
artikel |
2 |
A web-accessible complete transcriptome of normal human and DMD muscle
|
Bakay, Marina |
|
2002 |
12 |
S |
p. S125-S141 17 p. |
artikel |
3 |
CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci
|
Kapsa, R.M.I |
|
2002 |
12 |
S |
p. S61-S66 6 p. |
artikel |
4 |
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG)
|
Escolar, Diana M |
|
2002 |
12 |
S |
p. S147-S154 8 p. |
artikel |
5 |
Considerations to the policy of future clinical therapeutic trials in DMD
|
Reitter, Bernd |
|
2002 |
12 |
S |
p. S166-S168 3 p. |
artikel |
6 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Thioudellet, Christine |
|
2002 |
12 |
S |
p. S49-S51 3 p. |
artikel |
7 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Fardeau, Michel |
|
2002 |
12 |
S |
p. S52-S54 3 p. |
artikel |
8 |
Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies
|
Romero, Norma Beatriz |
|
2002 |
12 |
S |
p. S45-S48 4 p. |
artikel |
9 |
Dystrobrevin dynamics in muscle–cell signalling: a possible target for therapeutic intervention in Duchenne muscular dystrophy?
|
Blake, Derek J |
|
2002 |
12 |
S |
p. S110-S117 8 p. |
artikel |
10 |
Dystrophin and functionally related proteins in the nematode Caenorhabditis elegans
|
Ségalat, Laurent |
|
2002 |
12 |
S |
p. S105-S109 5 p. |
artikel |
11 |
Editorial Board
|
|
|
2002 |
12 |
S |
p. ii- 1 p. |
artikel |
12 |
Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice
|
Boer, Judith M. |
|
2002 |
12 |
S |
p. S118-S124 7 p. |
artikel |
13 |
Foreword
|
|
|
2002 |
12 |
S |
p. S1-S2 2 p. |
artikel |
14 |
Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
|
Wells, Dominic J |
|
2002 |
12 |
S |
p. S11-S22 12 p. |
artikel |
15 |
Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers
|
Courdier-Fruh, Isabelle |
|
2002 |
12 |
S |
p. S95-S104 10 p. |
artikel |
16 |
Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse
|
Gillis, Jean-Marie |
|
2002 |
12 |
S |
p. S90-S94 5 p. |
artikel |
17 |
Myoblast transplantation
|
Partridge, Terry |
|
2002 |
12 |
S |
p. S3-S6 4 p. |
artikel |
18 |
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?
|
Ferrari, Giuliana |
|
2002 |
12 |
S |
p. S7-S10 4 p. |
artikel |
19 |
Oligonucleotide-mediated gene therapy for muscular dystrophies
|
Rando, Thomas A |
|
2002 |
12 |
S |
p. S55-S60 6 p. |
artikel |
20 |
Pharmacological control of cellular calcium handling in dystrophic skeletal muscle
|
Ruegg, Urs T |
|
2002 |
12 |
S |
p. S155-S161 7 p. |
artikel |
21 |
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness
|
De Luca, Annamaria |
|
2002 |
12 |
S |
p. S142-S146 5 p. |
artikel |
22 |
Recombinant micro-genes and dystrophin viral vectors
|
Dickson, G |
|
2002 |
12 |
S |
p. S40-S44 5 p. |
artikel |
23 |
Screening for antisense modulation of dystrophin pre-mRNA splicing
|
Dickson, G |
|
2002 |
12 |
S |
p. S67-S70 4 p. |
artikel |
24 |
Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research
|
Muntoni, Francesco |
|
2002 |
12 |
S |
p. S162-S165 4 p. |
artikel |
25 |
Strategies for muscle-specific targeting of adenoviral gene transfer vectors
|
Thirion, Christian |
|
2002 |
12 |
S |
p. S30-S39 10 p. |
artikel |
26 |
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
|
Aartsma-Rus, Annemieke |
|
2002 |
12 |
S |
p. S71-S77 7 p. |
artikel |
27 |
The role of utrophin in the potential therapy of Duchenne muscular dystrophy
|
Perkins, Kelly J |
|
2002 |
12 |
S |
p. S78-S89 12 p. |
artikel |
28 |
Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin
|
Scott, Jeannine M |
|
2002 |
12 |
S |
p. S23-S29 7 p. |
artikel |